{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:48:58Z","timestamp":1793652538847,"version":"4.5.1"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.11863","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T11:06:54Z","timestamp":1652353614000},"page":"e2211863","source":"Crossref","is-referenced-by-count":73,"title":["Association of Thyroid Hormone Treatment Intensity With Cardiovascular Mortality Among US Veterans"],"prefix":"10.1001","volume":"5","author":[{"given":"Josh M.","family":"Evron","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Hummel","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Reyes-Gastelum","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan R.","family":"Haymart","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousumi","family":"Banerjee","sequence":"additional","affiliation":[{"name":"School of Public Health, Department of Biostatistics, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papaleontiou","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor"},{"name":"Institute of Gerontology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"issue":"10","key":"zoi220352r2","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics\u20142019 update: a report from the American Heart Association.","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"zoi220352r3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.7326\/M14-1753","article-title":"Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data.","volume":"163","author":"Patel","year":"2015","journal-title":"Ann Intern Med"},{"issue":"10","key":"zoi220352r4","doi-asserted-by":"publisher","first-page":"e3890","DOI":"10.1210\/clinem\/dgab444","article-title":"Thyroid hormone therapy and incident stroke.","volume":"106","author":"Papaleontiou","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"zoi220352r6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1210\/er.2013-1083","article-title":"Treatment with thyroid hormone.","volume":"35","author":"Biondi","year":"2014","journal-title":"Endocr Rev"},{"issue":"4","key":"zoi220352r8","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1210\/jc.2008-1696","article-title":"High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over.","volume":"94","author":"Somwaru","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"zoi220352r9","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1089\/thy.2015.0180","article-title":"Thyroid hormone therapy and risk of thyrotoxicosis in community-resident older adults: findings from the Baltimore Longitudinal Study of Aging.","volume":"25","author":"Mammen","year":"2015","journal-title":"Thyroid"},{"issue":"1","key":"zoi220352r10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1210\/jc.2009-1625","article-title":"Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy.","volume":"95","author":"Flynn","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"zoi220352r11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1089\/thy.2017.0517","article-title":"Over- and under-treatment of hypothyroidism is associated with excess mortality: a register-based cohort study.","volume":"28","author":"Lillevang-Johansen","year":"2018","journal-title":"Thyroid"},{"issue":"6","key":"zoi220352r12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1530\/EJE-19-0006","article-title":"Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk.","volume":"180","author":"Lillevang-Johansen","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"zoi220352r13","doi-asserted-by":"publisher","first-page":"l4892","DOI":"10.1136\/bmj.l4892","article-title":"Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study.","volume":"366","author":"Thayakaran","year":"2019","journal-title":"BMJ"},{"key":"zoi220352r14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.680647","article-title":"Risk of all-cause mortality in levothyroxine-treated hypothyroid patients: a nationwide Korean cohort study.","volume":"12","author":"Sohn","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"zoi220352r17","doi-asserted-by":"publisher","first-page":"I7","DOI":"10.1097\/00005650-200006001-00002","article-title":"Reinventing VA health care: systematizing quality improvement and quality innovation.","volume":"38","author":"Kizer","year":"2000","journal-title":"Med Care"},{"key":"zoi220352r18","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1097\/MLR.0000000000000683","article-title":"Accelerating research impact in a learning health care system: VA\u2019s Quality Enhancement Research Initiative in the Choice Act era.","volume":"55","author":"Kilbourne","year":"2017","journal-title":"Med Care"},{"issue":"7","key":"zoi220352r19","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1377\/hlthaff.2014.0054","article-title":"Insights from advanced analytics at the Veterans Health Administration.","volume":"33","author":"Fihn","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"zoi220352r22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000492324","article-title":"Association between thyroid-stimulating hormone levels and non-alcoholic fatty liver disease is not independent from metabolic syndrome criteria.","volume":"7","author":"Janovsky","year":"2018","journal-title":"Eur Thyroid J"},{"issue":"9","key":"zoi220352r23","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1634\/theoncologist.2019-0234","article-title":"Risk of osteoporosis and fractures in patients with thyroid cancer: a case-control study in U.S. veterans.","volume":"24","author":"Papaleontiou","year":"2019","journal-title":"Oncologist"},{"issue":"6","key":"zoi220352r24","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1089\/thy.2019.0414","article-title":"Impact of a forced dose-equivalent levothyroxine brand switch on plasma thyrotropin: a cohort study.","volume":"30","author":"Flinterman","year":"2020","journal-title":"Thyroid"},{"issue":"1","key":"zoi220352r25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1001\/jamainternmed.2013.11312","article-title":"Falling threshold for treatment of borderline elevated thyrotropin levels\u2014balancing benefits and risks: evidence from a large community-based study.","volume":"174","author":"Taylor","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"5","key":"zoi220352r26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004966","article-title":"Comparison of expert adjudicated coronary heart disease and cardiovascular disease mortality with the National Death Index: results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.","volume":"6","author":"Olubowale","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"zoi220352r27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1012848","article-title":"Lifetime risks of cardiovascular disease.","volume":"366","author":"Berry","year":"2012","journal-title":"N Engl J Med"},{"key":"zoi220352r5","first-page":"46","volume-title":"Medicine Use and Shifting Costs of Healthcare","author":"IMS Institute for Healthcare Informatics","year":"2014"},{"key":"zoi220352r1","unstructured":"Centers for Disease Control and Prevention. Heart disease. Accessed July 29, 2021. https:\/\/www.cdc.gov\/nchs\/fastats\/heart-disease.htm"},{"key":"zoi220352r7","unstructured":"IQVIA. Medicine use and spending in the U.S.: a review of 2018 and outlook to 2023. Accessed July 1, 2021. https:\/\/www.iqvia.com\/insights\/the-iqvia-institute\/reports\/medicine-use-and-spending-in-the-us-a-review-of-2018-and-outlook-to-2023"},{"key":"zoi220352r15","unstructured":"U.S. Department of Veterans Affairs. VA Informatics and Computing Infrastructure (VINCI). 2018. Accessed July 1, 2020. https:\/\/www.research.va.gov\/programs\/vinci\/default.cfm"},{"key":"zoi220352r16","unstructured":"U.S. Department of Veterans Affairs. Veterans Health Administration. Accessed April 10, 2021. https:\/\/www.va.gov\/health\/"},{"key":"zoi220352r20","unstructured":"Centers for Disease Control and Prevention. National Death Index. Accessed July 1, 2020. https:\/\/www.cdc.gov\/nchs\/ndi\/index.htm"},{"key":"zoi220352r21","unstructured":"Von Elm? E, Altman? DG, Egger? M, Pocock? SJ, Gotzsche? PC, Vandenbroucke? JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Accessed March 22, 2022. https:\/\/www.equator-network.org\/reporting-guidelines\/strobe\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2792219\/evron_2022_oi_220352_1651764554.6946.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T11:06:59Z","timestamp":1652353619000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2792219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.11863","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742140576.793597397","asserted-by":"object"}]},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]}}}